115 related articles for article (PubMed ID: 7512195)
1. Activation of protein kinase C alpha inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1.
Chin JE; Liu F; Roth RA
Mol Endocrinol; 1994 Jan; 8(1):51-8. PubMed ID: 7512195
[TBL] [Abstract][Full Text] [Related]
2. Activation of protein kinase C alpha inhibits signaling by members of the insulin receptor family.
Danielsen AG; Liu F; Hosomi Y; Shii K; Roth RA
J Biol Chem; 1995 Sep; 270(37):21600-5. PubMed ID: 7545165
[TBL] [Abstract][Full Text] [Related]
3. Effects of chromium on basal and insulin-induced tyrosine phosphorylation in H4 hepatoma cells: comparison with phorbol-12-myristate-13-acetate and sodium orthovanadate.
Yurkow EJ; Kim G
Mol Pharmacol; 1995 Apr; 47(4):686-95. PubMed ID: 7536887
[TBL] [Abstract][Full Text] [Related]
4. Insulin-stimulated tyrosine phosphorylation of protein kinase C alpha: evidence for direct interaction of the insulin receptor and protein kinase C in cells.
Liu F; Roth RA
Biochem Biophys Res Commun; 1994 May; 200(3):1570-7. PubMed ID: 7514404
[TBL] [Abstract][Full Text] [Related]
5. Effect of phosphotyrosyl-IRS-1 level and insulin receptor tyrosine kinase activity on insulin-stimulated phosphatidylinositol 3, MAP, and S6 kinase activities.
Wilden PA; Broadway DE
J Cell Physiol; 1995 Apr; 163(1):9-18. PubMed ID: 7896903
[TBL] [Abstract][Full Text] [Related]
6. Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone.
Saad MJ; Folli F; Araki E; Hashimoto N; Csermely P; Kahn CR
Mol Endocrinol; 1994 May; 8(5):545-57. PubMed ID: 7520127
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C isoforms alpha, delta and theta require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells).
Kellerer M; Mushack J; Seffer E; Mischak H; Ullrich A; Häring HU
Diabetologia; 1998 Jul; 41(7):833-8. PubMed ID: 9686926
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes.
Zhang B; Szalkowski D; Diaz E; Hayes N; Smith R; Berger J
J Biol Chem; 1994 Oct; 269(41):25735-41. PubMed ID: 7929278
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate.
Valverde AM; Teruel T; Lorenzo M; Benito M
Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.
De Fea K; Roth RA
Biochemistry; 1997 Oct; 36(42):12939-47. PubMed ID: 9335553
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
Batty IH; Fleming IN; Downes CP
Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C plays a role in the induction of tyrosine phosphorylation of lymphoid microtubule-associated protein-2 kinase. Evidence for a CD3-associated cascade that includes pp56lck and that is defective in HPB-ALL.
Nel AE; Hanekom C; Hultin L
J Immunol; 1991 Sep; 147(6):1933-9. PubMed ID: 1716287
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C inhibits insulin-induced Akt activation in vascular smooth muscle cells.
Motley ED; Kabir SM; Eguchi K; Hicks AL; Gardner CD; Reynolds CM; Frank GD; Eguchi S
Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1059-62. PubMed ID: 11785657
[TBL] [Abstract][Full Text] [Related]
14. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells.
Hara K; Yonezawa K; Sakaue H; Ando A; Kotani K; Kitamura T; Kitamura Y; Ueda H; Stephens L; Jackson TR
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7415-9. PubMed ID: 8052599
[TBL] [Abstract][Full Text] [Related]
15. The level of insulin receptor tyrosine kinase activity modulates the activities of phosphatidylinositol 3-kinase, microtubule-associated protein, and S6 kinases.
Wilden PA; Kahn CR
Mol Endocrinol; 1994 May; 8(5):558-67. PubMed ID: 8058065
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
[TBL] [Abstract][Full Text] [Related]
17. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C.
Teng JM; Liu XR; Mills GB; Dupont B
J Immunol; 1996 May; 156(9):3222-32. PubMed ID: 8617944
[TBL] [Abstract][Full Text] [Related]
18. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.
Zhang-Sun G; Yang C; Viallet J; Feng G; Bergeron JJ; Posner BI
Endocrinology; 1996 Jul; 137(7):2649-58. PubMed ID: 8770882
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the in situ tyrosine kinase activity of mutant insulin receptors lacking tyrosine autophosphorylation sites 1162 and 1163.
Yonezawa K; Roth RA
Mol Endocrinol; 1991 Feb; 5(2):194-200. PubMed ID: 1710030
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells.
Einspahr KJ; Abraham RT; Dick CJ; Leibson PJ
J Immunol; 1990 Sep; 145(5):1490-7. PubMed ID: 1696599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
